Pictures

Photo

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Photo caption 

Photo

Weird homes

Home is where the heart is, no matter what unusual form that home may take.  Slideshow 

Photo

The drone wars

The frontlines of America's covert drone program.  Slideshow 

Sponsored Links

Galapagos secures milestone payment from GSK

Related Topics

Signage is pictured on the company headquarters of GlaxoSmithKline in west London July 21, 2008. GlaxoSmithKline announce their half yearly results on Wednesday July 23. REUTERS/Toby Melville

Signage is pictured on the company headquarters of GlaxoSmithKline in west London July 21, 2008. GlaxoSmithKline announce their half yearly results on Wednesday July 23.

Credit: Reuters/Toby Melville

BRUSSELS | Wed Jan 9, 2013 1:49am EST

BRUSSELS (Reuters) - Belgian biopharmaceutical company Galapagos said on Wednesday it had delivered a fifth pre-clinical drug candidate to GlaxoSmithKline, triggering a milestone payment.

Galapagos did not specify the amount of the payment, which is the result of 2006 alliance signed by the two companies related to medicines to fight immuno-inflammatory diseases.

According to the companies' agreement, Galapagos has the potential to receive more than 200 million euros in total milestone payments, plus up to double-digit percentage royalties.

(Reporting By Philip Blenkinsop)
Health
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.